Christopher W. Fulton

Array ( [id] => 5800224 [patent_doc_number] => 20060035302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Kinase substrates with multiple phosphorylation sites' [patent_app_type] => utility [patent_app_number] => 11/158525 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23260 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035302.pdf [firstpage_image] =>[orig_patent_app_number] => 11158525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738104 [patent_doc_number] => 20060008494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Complete inactivation of infectious proteins' [patent_app_type] => utility [patent_app_number] => 11/157488 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8898 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008494.pdf [firstpage_image] =>[orig_patent_app_number] => 11157488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 345120 [patent_doc_number] => 07498307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Combinations of DnaK inhibitors with known antibacterial agents' [patent_app_type] => utility [patent_app_number] => 11/155409 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6556 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498307.pdf [firstpage_image] =>[orig_patent_app_number] => 11155409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649702 [patent_doc_number] => 20060135437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Novel use of peptide compounds for treating pain in trigeminal neuralgia' [patent_app_type] => utility [patent_app_number] => 11/148429 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7853 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135437.pdf [firstpage_image] =>[orig_patent_app_number] => 11148429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926451 [patent_doc_number] => 20050239707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Combined use of derivatives of GLP-1 analogs and PPAR ligands' [patent_app_type] => utility [patent_app_number] => 11/146780 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5350 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239707.pdf [firstpage_image] =>[orig_patent_app_number] => 11146780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256389 [patent_doc_number] => 07576062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Compounds with growth hormone releasing properties' [patent_app_type] => utility [patent_app_number] => 11/147017 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22942 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/576/07576062.pdf [firstpage_image] =>[orig_patent_app_number] => 11147017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250212 [patent_doc_number] => 20050272668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Anti-inflammatory compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/147601 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16698 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272668.pdf [firstpage_image] =>[orig_patent_app_number] => 11147601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793553 [patent_doc_number] => 20060014234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Method for the enrichment and characterization of phosphorylated peptides or proteins' [patent_app_type] => utility [patent_app_number] => 11/147073 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12975 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 59 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014234.pdf [firstpage_image] =>[orig_patent_app_number] => 11147073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7603404 [patent_doc_number] => 07235628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Analogues of GLP-1' [patent_app_type] => utility [patent_app_number] => 11/145782 [patent_app_country] => US [patent_app_date] => 2005-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19275 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235628.pdf [firstpage_image] =>[orig_patent_app_number] => 11145782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931721 [patent_doc_number] => 20050282756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Oral delivery of peptide pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/144580 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10497 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282756.pdf [firstpage_image] =>[orig_patent_app_number] => 11144580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669390 [patent_doc_number] => 20080044450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Sustained Release Composition' [patent_app_type] => utility [patent_app_number] => 11/628036 [patent_app_country] => US [patent_app_date] => 2005-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12021 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044450.pdf [firstpage_image] =>[orig_patent_app_number] => 11628036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829216 [patent_doc_number] => 20060063807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Low molecular weight peptidomimetic growth hormone secretagogues' [patent_app_type] => utility [patent_app_number] => 11/138705 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 43908 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063807.pdf [firstpage_image] =>[orig_patent_app_number] => 11138705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670634 [patent_doc_number] => 20080045694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Preparation of Solid Phase Bound Peptides or Pnas' [patent_app_type] => utility [patent_app_number] => 11/597693 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5270 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045694.pdf [firstpage_image] =>[orig_patent_app_number] => 11597693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925907 [patent_doc_number] => 20050239162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Process for folding chemically synthesized polypeptides' [patent_app_type] => utility [patent_app_number] => 11/132987 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5774 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239162.pdf [firstpage_image] =>[orig_patent_app_number] => 11132987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808310 [patent_doc_number] => 20060094665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Pharmaceutical angiostatic dipeptide compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/129367 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7991 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094665.pdf [firstpage_image] =>[orig_patent_app_number] => 11129367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020100 [patent_doc_number] => 20050222119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4' [patent_app_type] => utility [patent_app_number] => 11/128732 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86623 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222119.pdf [firstpage_image] =>[orig_patent_app_number] => 11128732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926434 [patent_doc_number] => 20050239690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Intermediate for preparing glycopeptide derivatives' [patent_app_type] => utility [patent_app_number] => 11/128901 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29916 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239690.pdf [firstpage_image] =>[orig_patent_app_number] => 11128901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629544 [patent_doc_number] => 08008433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Methods for preventing or treating bone disorders' [patent_app_type] => utility [patent_app_number] => 11/579124 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11078 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008433.pdf [firstpage_image] =>[orig_patent_app_number] => 11579124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7171951 [patent_doc_number] => 20050203006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Novel lipopeptides as antibacterial agents' [patent_app_type] => utility [patent_app_number] => 11/121851 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16436 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203006.pdf [firstpage_image] =>[orig_patent_app_number] => 11121851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925954 [patent_doc_number] => 20050239209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Method for peptide and polypeptide purification and differential analysis' [patent_app_type] => utility [patent_app_number] => 11/112896 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4637 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239209.pdf [firstpage_image] =>[orig_patent_app_number] => 11112896 [rel_patent_id] =>[rel_patent_doc_number] =>)